Pharma in Focus
Email Address Sign-Up

Australia's most trusted source of pharma news

Buy now fake rolex

News

Pfizer AE hits Aussie teens

Posted 10 September 2021 AM

Two weeks since Pfizer's Comirnaty was approved for use in children over the age of 12, the TGA has received a dozen reports of suspected cases of heart inflammation after vaccination in teens aged between 15 and 17, mostly boys.

The latest  COVID-19 Vaccine Weekly Safety Report released yesterday (Thursday), reveals to 5 September, the TGA had received 370 reports of suspected myocarditis (inflammation of the heart) and/or pericarditis (inflammation of the membrane around the heart) following vaccination with Comirnaty.

Looks like you've lost your access to Pharma in Focus. To restore access or update your subscription, click here

Approvals Action
Melb pharma registers first copy
Long list of generic versions of PBS-listed drugs